Lamberti Frank 4

What Happened Frank Lamberti, Chief Commercial Officer of Herbalife Ltd. (HLF), was granted 40,437 stock appreciation rights (SARs) on February 25, 2026. The Form 4 reports an acquisition price of $0 (the grant is a derivative award rather than an open‑market purchase or sale). This is a compensation award, not an immediate purchase of shares or a sale.

Key Details

• Transaction date: 2026-02-25; filing date: 2026-02-27 (filed on Form 4).
• Grant: 40,437 SARs; acquisition price reported as $0 (derivative award).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: SARs granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan; vest one‑third on Feb 25 of 2027, 2028 and 2029, subject to continued service.
• No indication in the filing that this was a sale, tax withholding, or part of a 10b5-1 plan.

Context SARs are a form of equity compensation that give the holder the right to receive the appreciation in the company’s stock (often settled in cash or stock) if certain conditions are met; they are not an immediate market purchase and do not necessarily signal buying or selling intent. Vesting over three years means the economic benefit depends on future service and any future stock price movement.